RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Laryngeal Neoplasms
Accession: DOID:9003613
browse the term
Definition: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
Synonyms: exact_synonym: Laryngeal Neoplasm; laryngeal tumor; larynx neoplasm; larynx neoplasms; neoplasm of larynx
primary_id: MESH:D007822
xref: EFO:0003817
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18500343
NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:226,741,788...226,763,182
G
Egfr
epidermal growth factor receptor
severity
ISO
protein:increased expression:tumor (human)
RGD
PMID:8883413
RGD:5131485
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
susceptibility
ISO
DNA:snp:exon:c.354T>C (human) (rs11615)
RGD
PMID:24582975
RGD:13207310
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Gstp1
glutathione S-transferase pi 1
ISO
protein:increased expression:larynx
RGD
PMID:18335753
RGD:4140949
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Mir10a
microRNA 10a
sexual_dimorphism
ISO
miRNA:decreased expression:larynx epithelium (human)
RGD
PMID:25266939
RGD:153344531
NCBI chr10:81,779,709...81,779,818
Ensembl chr10:81,283,171...81,283,280
G
Mir34c
microRNA 34c
sexual_dimorphism
ISO
miRNA:increased expression:larynx epithelium (human)
RGD
PMID:25266939
RGD:153344531
NCBI chr 8:60,306,091...60,306,167
Ensembl chr 8:51,409,726...51,409,802
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:17786346
RGD:5130203
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Nat1
N-acetyltransferase 1
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:12037388
RGD:5131864
NCBI chr16:26,984,882...27,005,194
Ensembl chr16:22,208,194...22,238,520
G
Ptgs2
prostaglandin-endoperoxide synthase 2
severity
ISO
protein:increased expression:larynx
RGD
PMID:20429377
RGD:5135434
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:16299231
RGD:1581365
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
G
Wrap53
WD repeat containing, antisense to TP53
disease_progression
ISO
RGD
PMID:28849066
RGD:21081521
NCBI chr10:54,780,873...54,797,919
Ensembl chr10:54,282,105...54,298,929
G
Ackr3
atypical chemokine receptor 3
disease_progression
ISO
protein:increased expression:larynx (human)
RGD
PMID:16494043
RGD:152025548
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:90,799,686...90,811,237
G
Cxcr4
C-X-C motif chemokine receptor 4
disease_progression
ISO
protein:increased expression:larynx (human)
RGD
PMID:16494043
RGD:152025548
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Kmt2c
lysine methyltransferase 2C
ISO
mRNA:decreased expression:larynx
RGD
PMID:25633166
RGD:151356763
NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:9,609,627...9,833,539
G
Socs1
suppressor of cytokine signaling 1
severity
ISO
RGD
PMID:20164024
RGD:150573814
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Traf6
TNF receptor associated factor 6
disease_progression
ISO
RGD
PMID:20164024
RGD:150573814
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507
G
Ubr5
ubiquitin protein ligase E3 component n-recognin 5
exacerbates
ISO
mRNA, protein:increased expression:larynx (human)
RGD
PMID:32468011
RGD:151665191
NCBI chr 7:71,000,197...71,109,841
Ensembl chr 7:69,116,761...69,224,903
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:missense mutation:cds: p.R280H (human) DNA:SNPs, haplotype:: (rs3213403, rs1799778, rs3213282) (human)
RGD
PMID:27808358 PMID:24956286
RGD:151236313 , RGD:151236314
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:19736197
RGD:5135499
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Serpina3n
serpin family A member 3N
ISO
protein:decreased expression:serum
RGD
PMID:16273852
RGD:5147435
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:123,323,629...123,332,433
G
Tap1
transporter 1, ATP binding cassette subfamily B member
ISO
RGD
PMID:10618282
RGD:5147846
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901
G
Ada
adenosine deaminase
ISO
protein:decreased activity:larynx
RGD
PMID:8138195
RGD:152995273
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088
G
Cat
catalase
ISO
protein:increased activity:larynx
RGD
PMID:8138195
RGD:152995273
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cdc73
cell division cycle 73
disease_progression
ISO
protein:decreased expression:larynx (human)
RGD
PMID:27334641
RGD:150539447
NCBI chr13:57,897,924...58,000,031
Ensembl chr13:55,357,226...55,449,656
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
ISO
RGD
PMID:15646812
RGD:8662837
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Chd4
chromodomain helicase DNA binding protein 4
exacerbates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:33315534
RGD:153323310
NCBI chr 4:159,584,623...159,617,867
Ensembl chr 4:157,899,391...157,931,541
G
Egfr
epidermal growth factor receptor
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Erbb2
erb-b2 receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:996,225...1,015,525
G
Erbb4
erb-b2 receptor tyrosine kinase 4
disease_progression
ISO
RGD
PMID:22549618
RGD:126790474
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
G
Foxl2
forkhead box L2
exacerbates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:32517588
RGD:151667913
NCBI chr 8:108,392,466...108,395,553
Ensembl chr 8:99,513,303...99,514,427
G
Gpx1
glutathione peroxidase 1
disease_progression no_association
ISO
protein:increased expression:larynx (human) DNA:missense mutation:CDS:p.P198L (human) DNA:missense mutation:CDS:p.P198L (rs1050450) (human)
RGD
PMID:28641905 PMID:24074040 PMID:27188866
RGD:152995454 , RGD:152995493 , RGD:152995455
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Map2k4
mitogen activated protein kinase kinase 4
severity
ISO
associated with Neoplasm Metastasis; protein:mRNA,increased expression:larynx epithelium (human)
RGD
PMID:19513509
RGD:150429781
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Mir10a
microRNA 10a
severity
ISO
miRNA:decreased expression:blood serum (human)
RGD
PMID:35117730
RGD:153344530
NCBI chr10:81,779,709...81,779,818
Ensembl chr10:81,283,171...81,283,280
G
Mir136
microRNA 136
ISO
RNA:decreased expression:larynx (human)
RGD
PMID:32014687
RGD:153344610
NCBI chr 6:134,331,335...134,331,416
Ensembl chr 6:128,549,096...128,549,177
G
Mir21
microRNA 21
exacerbates
ISO
miRNA:increased expression:blood serum (human)
RGD
PMID:35117730
RGD:153344530
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mir31
microRNA 31
disease_progression
ISO
RNA:decreased expression:mucosa of larynx (human)
RGD
PMID:29737563
RGD:152998933
NCBI chr 5:108,714,849...108,714,954
G
Mlh1
mutL homolog 1
disease_progression
ISO
mRNA:decreased expression:larynx
RGD
PMID:23787767
RGD:126848783
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:111,196,468...111,233,617
G
Mmp2
matrix metallopeptidase 2
ISO
RGD
PMID:17786346
RGD:5130203
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Msh2
mutS homolog 2
disease_progression
ISO
mRNA:decreased expression:larynx
RGD
PMID:23787767
RGD:126848783
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:19922706 PMID:16155914
RGD:5131602 , RGD:5131856
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:22,208,194...22,238,520
G
Plcg1
phospholipase C, gamma 1
ameliorates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:33466212
RGD:151665160
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:149,385,587...149,416,330
G
Rela
RELA proto-oncogene, NF-kB subunit
severity
ISO
associated with Neoplasm Metastasis; protein:mRNA,increased expression:larynx epithelium (human)
RGD
PMID:19513509
RGD:150429781
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Xdh
xanthine dehydrogenase
ISO
protein:increased activity:larynx
RGD
PMID:8138195
RGD:152995273
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Xrcc1
X-ray repair cross complementing 1
ISO
ClinVar Annotator: match by term: Laryngeal squamous cell carcinoma
ClinVar
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:80,141,207...80,168,701
G
Cxcl12
C-X-C motif chemokine ligand 12
exacerbates
ISO
protein:increased expression: mucosa of larynx (human)
RGD
PMID:23259294
RGD:152177474
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:150,388,325...150,401,168
G
Cxcr4
C-X-C motif chemokine receptor 4
exacerbates
ISO
protein:increased expression: mucosa of larynx (human)
RGD
PMID:23259294
RGD:152177474
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Ercc5
ERCC excision repair 5, endonuclease
susceptibility
ISO
DNA:missense mutation:CDS:p.D1104H (human)
RGD
PMID:19444904
RGD:155260337
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:46,309,389...46,354,472
G
Ercc6
ERCC excision repair 6, chromatin remodeling factor
susceptibility
ISO
DNA:missense mutation:CDS:p.R1230P (human)
RGD
PMID:19444904
RGD:155260337
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,765,013...7,835,587
G
Gpx1
glutathione peroxidase 1
susceptibility
ISO
DNA:missense mutation:CDS: (rs1050450) (human)
RGD
PMID:23516596
RGD:152998903
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gstm1
glutathione S-transferase mu 1
ISO
DNA:deletion: :
RGD
PMID:19252926
RGD:4140943
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstm3
glutathione S-transferase mu 3
ISO
RGD
PMID:10067818
RGD:5135043
NCBI chr 2:198,295,442...198,300,742
Ensembl chr 2:195,607,289...195,612,475
G
Gstm5
glutathione S-transferase, mu 5
ISO
RGD
PMID:10067818
RGD:5135043
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:195,531,495...195,534,553
G
Map2k7
mitogen activated protein kinase kinase 7
ameliorates
ISO
mRNA:increased expression:larynx (human)
RGD
PMID:32791689
RGD:155256869
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:2,591,219...2,604,222
G
Nod2
nucleotide-binding oligomerization domain containing 2
onset
ISO
DNA:insertion:Cds: 3020_3021insC (human)
RGD
PMID:20223031
RGD:5131515
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
RGD
PMID:20967863
RGD:126925200
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all